Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Saxagliptin (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 25 Oct 2017 Status changed from active, no longer recruiting to completed.
- 31 Jan 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.
- 31 Jan 2017 Status changed from recruiting to active, no longer recruiting.